Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 284.00 | 276.50 | 1.0271 | 1.0885 | |
| SK-BR-3 | Etoposide | 10 | uM | 4 | 312.50 | 180.13 | 121.00 | 276.50 | 0.4376 | -0.4746 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 278.00 | 276.50 | 1.0054 | 1.0176 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 289.00 | 276.50 | 1.0452 | 1.1483 | |
| SK-BR-3 | Etoposide | 1 | uM | 4 | 312.50 | 180.13 | 169.00 | 276.50 | 0.6112 | -0.0980 |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 4 | 312.50 | 180.13 | 181.00 | 276.50 | 0.6546 | 0.0079 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 4 | 312.50 | 180.13 | 335.00 | 276.50 | 1.2116 | 1.7280 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 4 | 312.50 | 180.13 | 322.00 | 276.50 | 1.1646 | 1.5588 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 4 | 312.50 | 180.13 | 353.00 | 276.50 | 1.2767 | 1.9689 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 4 | 312.50 | 180.13 | 307.00 | 276.50 | 1.1103 | 1.3688 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 307.00 | 276.50 | 1.1103 | 1.3688 | |
| SK-BR-3 | Etoposide | 0.1 | uM | 4 | 312.50 | 180.13 | 245.00 | 276.50 | 0.8861 | 0.6446 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 4 | 312.50 | 180.13 | 297.00 | 276.50 | 1.0741 | 1.2453 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 4 | 312.50 | 180.13 | 245.00 | 276.50 | 0.8861 | 0.6446 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 4 | 312.50 | 180.13 | 271.00 | 276.50 | 0.9801 | 0.9361 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 4 | 312.50 | 180.13 | 368.00 | 276.50 | 1.3309 | 2.1757 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 4 | 312.50 | 180.13 | 252.00 | 276.50 | 0.9114 | 0.7213 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 4 | 312.50 | 180.13 | 199.00 | 276.50 | 0.7197 | 0.1749 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 4 | 312.50 | 180.13 | 285.00 | 276.50 | 1.0307 | 1.1004 |
| SK-BR-3 | PLX-4720 | 1 | uM | 4 | 312.50 | 180.13 | 286.00 | 276.50 | 1.0344 | 1.1123 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 4 | 312.50 | 180.13 | 188.00 | 276.50 | 0.6799 | 0.0717 |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 253.00 | 276.50 | 0.9150 | 0.7324 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 261.00 | 276.50 | 0.9439 | 0.8218 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 199.00 | 276.50 | 0.7197 | 0.1749 | |
| SK-BR-3 | 0 | uM | 4 | 312.50 | 180.13 | 255.00 | 276.50 | 0.9222 | 0.7546 |